Literature DB >> 27297950

Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.

Kazumi Taguchi1,2, Shuzo Hamamoto1, Atsushi Okada3, Rei Unno1, Hideyuki Kamisawa1,2, Taku Naiki1, Ryosuke Ando1, Kentaro Mizuno1, Noriyasu Kawai1, Keiichi Tozawa1, Kenjiro Kohri1, Takahiro Yasui1.   

Abstract

Randall plaques (RPs) can contribute to the formation of idiopathic calcium oxalate (CaOx) kidney stones; however, genes related to RP formation have not been identified. We previously reported the potential therapeutic role of osteopontin (OPN) and macrophages in CaOx kidney stone formation, discovered using genome-recombined mice and genome-wide analyses. Here, to characterize the genetic pathogenesis of RPs, we used microarrays and immunohistology to compare gene expression among renal papillary RP and non-RP tissues of 23 CaOx stone formers (SFs) (age- and sex-matched) and normal papillary tissue of seven controls. Transmission electron microscopy showed OPN and collagen expression inside and around RPs, respectively. Cluster analysis revealed that the papillary gene expression of CaOx SFs differed significantly from that of controls. Disease and function analysis of gene expression revealed activation of cellular hyperpolarization, reproductive development, and molecular transport in papillary tissue from RPs and non-RP regions of CaOx SFs. Compared with non-RP tissue, RP tissue showed upregulation (˃2-fold) of LCN2, IL11, PTGS1, GPX3, and MMD and downregulation (0.5-fold) of SLC12A1 and NALCN (P<0.01). In network and toxicity analyses, these genes associated with activated mitogen-activated protein kinase, the Akt/phosphatidylinositol 3-kinase pathway, and proinflammatory cytokines that cause renal injury and oxidative stress. Additionally, expression of proinflammatory cytokines, numbers of immune cells, and cellular apoptosis increased in RP tissue. This study establishes an association between genes related to renal dysfunction, proinflammation, oxidative stress, and ion transport and RP development in CaOx SFs.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Randall’s plaque; calcium oxalate; ingenuity pathway analysis; kidney stone disease; microarray; renal papilla

Mesh:

Substances:

Year:  2016        PMID: 27297950      PMCID: PMC5198277          DOI: 10.1681/ASN.2015111271

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  HISTOCHEMICAL RECOGNITION OF CALCIUM OXALATE.

Authors:  P PIZZOLATO
Journal:  J Histochem Cytochem       Date:  1964-05       Impact factor: 2.479

2.  A replication study for three nephrolithiasis loci at 5q35.3, 7p14.3 and 13q14.1 in the Japanese population.

Authors:  Takahiro Yasui; Atsushi Okada; Yuji Urabe; Masayuki Usami; Kentaro Mizuno; Yasue Kubota; Keiichi Tozawa; Shoichi Sasaki; Yoshihito Higashi; Yoshikazu Sato; Michiaki Kubo; Yusuke Nakamura; Koichi Matsuda; Kenjiro Kohri
Journal:  J Hum Genet       Date:  2013-05-30       Impact factor: 3.172

Review 3.  Retention and growth of urinary stones: insights from imaging.

Authors:  James C Williams; James A McAteer
Journal:  J Nephrol       Date:  2013 Jan-Feb       Impact factor: 3.902

4.  Urolithiasis and the risk of ESRD.

Authors:  Ziad M El-Zoghby; John C Lieske; Robert N Foley; Eric J Bergstralh; Xujian Li; L Joseph Melton; Amy E Krambeck; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

5.  IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI.

Authors:  Joo Yun Kim; Mihwa Kim; Ahrom Ham; Kevin M Brown; Robert W Greene; Vivette D D'Agati; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

6.  Association of osteopontin gene haplotypes with nephrolithiasis.

Authors:  B Gao; T Yasui; Y Itoh; Z Li; A Okada; K Tozawa; Y Hayashi; K Kohri
Journal:  Kidney Int       Date:  2007-05-23       Impact factor: 10.612

7.  Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005.

Authors:  Takahiro Yasui; Masanori Iguchi; Sadao Suzuki; Kenjiro Kohri
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

8.  Vasomotor Reaction to Cyclooxygenase-1-Mediated Prostacyclin Synthesis in Carotid Arteries from Two-Kidney-One-Clip Hypertensive Mice.

Authors:  Bin Liu; Zhenhua Li; Yingzhan Zhang; Wenhong Luo; Jiling Zhang; Hui Li; Yingbi Zhou
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  C-phycocyanin confers protection against oxalate-mediated oxidative stress and mitochondrial dysfunctions in MDCK cells.

Authors:  Shukkur M Farooq; Nithin B Boppana; Asokan Devarajan; Devarajan Asokan; Shamala D Sekaran; Esaki M Shankar; Chunying Li; Kaliappan Gopal; Sazaly A Bakar; Harve S Karthik; Abdul S Ebrahim
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

10.  Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?

Authors:  Emmanuel Letavernier; Sophie Vandermeersch; Olivier Traxer; Mohamed Tligui; Laurent Baud; Pierre Ronco; Jean-Philippe Haymann; Michel Daudon
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more
  40 in total

1.  Optimizing RNA Extraction of Renal Papilla Biopsy Tissue in Kidney Stone Formers: A New Methodology for Genomic Study.

Authors:  Kazumi Taguchi; Manint Usawachintachit; Shuzo Hamamoto; Rei Unno; David T Tzou; Benjamin A Sherer; Yongmei Wang; Atsushi Okada; Marshall L Stoller; Takahiro Yasui; Thomas Chi
Journal:  J Endourol       Date:  2017-08-11       Impact factor: 2.942

2.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

3.  Clinical physiology of the kidney, electrolytes and lithiasis. The "old" meets the "new".

Authors:  Pietro Manuel Ferraro; Daniel Guido Fuster
Journal:  J Nephrol       Date:  2021-02       Impact factor: 3.902

4.  How do stones form? Is unification of theories on stone formation possible?

Authors:  Victoria Y Bird; Saeed R Khan
Journal:  Arch Esp Urol       Date:  2017-01       Impact factor: 0.436

Review 5.  [Current concepts on the pathogenesis of urinary stones].

Authors:  R Mager; A Neisius
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

6.  Deregulated MTOR (mechanistic target of rapamycin kinase) is responsible for autophagy defects exacerbating kidney stone development.

Authors:  Rei Unno; Tsuyoshi Kawabata; Kazumi Taguchi; Teruaki Sugino; Shuzo Hamamoto; Ryosuke Ando; Atsushi Okada; Kenjiro Kohri; Tamotsu Yoshimori; Takahiro Yasui
Journal:  Autophagy       Date:  2019-06-29       Impact factor: 16.016

7.  Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone Disease.

Authors:  Pegah Dejban; Elena M Wilson; Muthuvel Jayachandran; Loren P Herrera Hernandez; Zejfa Haskic; Linda E Wellik; Sutapa Sinha; Andrew D Rule; Aleksandar Denic; Kevin Koo; Aaron M Potretzke; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2022-01-25       Impact factor: 8.237

Review 8.  Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.

Authors:  John A Sayer
Journal:  J Am Soc Nephrol       Date:  2016-12-08       Impact factor: 10.121

Review 9.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

10.  Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.

Authors:  Kazumi Taguchi; Atsushi Okada; Rei Unno; Shuzo Hamamoto; Takahiro Yasui
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.